Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis

Abstract Background Controversial findings have been reported in the impact of speckle-type POZ protein (SPOP) on clinicopathological features and prognosis in diverse cancers. We conducted this meta-analysis to confirm whether SPOP was an effective biomarker to predict clinical stage, cancer differ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yan He, Jun Chen, Xingchen Peng, Yanli Xia, Yonglin Su
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/d74b95125b3e4e56ab0cdce7248bd8e1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d74b95125b3e4e56ab0cdce7248bd8e1
record_format dspace
spelling oai:doaj.org-article:d74b95125b3e4e56ab0cdce7248bd8e12021-11-28T12:37:00ZClinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis10.1186/s12935-021-02329-51475-2867https://doaj.org/article/d74b95125b3e4e56ab0cdce7248bd8e12021-11-01T00:00:00Zhttps://doi.org/10.1186/s12935-021-02329-5https://doaj.org/toc/1475-2867Abstract Background Controversial findings have been reported in the impact of speckle-type POZ protein (SPOP) on clinicopathological features and prognosis in diverse cancers. We conducted this meta-analysis to confirm whether SPOP was an effective biomarker to predict clinical stage, cancer differentiation and survival. Methods We searched studies published before June 2021 through Medline, Embase, the Cochrane library register of controlled trials and Wanfang databases. The corrections of SPOP expression with expression disparity, tumor differentiation, clinical stage and survival were analyzed. Results Our meta-analysis found that higher expression of SPOP was significantly associated with earlier clinical stage, well differentiation and better overall survival. Subgroup analysis showed that the SPOP expression of adjacent tissue was significantly higher than that in cancer tissues of prostate and liver. However, renal cancer presented improved expression of SPOP in cancer tissue. Conclusions SPOP has the potential function to act as a novel and effective biomarker for cancer diagnosis and prognostic stratification.Yan HeJun ChenXingchen PengYanli XiaYonglin SuBMCarticleSpeckle-type POZ proteinCancerBiomarkerMeta-analysisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282CytologyQH573-671ENCancer Cell International, Vol 21, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Speckle-type POZ protein
Cancer
Biomarker
Meta-analysis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Cytology
QH573-671
spellingShingle Speckle-type POZ protein
Cancer
Biomarker
Meta-analysis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Cytology
QH573-671
Yan He
Jun Chen
Xingchen Peng
Yanli Xia
Yonglin Su
Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
description Abstract Background Controversial findings have been reported in the impact of speckle-type POZ protein (SPOP) on clinicopathological features and prognosis in diverse cancers. We conducted this meta-analysis to confirm whether SPOP was an effective biomarker to predict clinical stage, cancer differentiation and survival. Methods We searched studies published before June 2021 through Medline, Embase, the Cochrane library register of controlled trials and Wanfang databases. The corrections of SPOP expression with expression disparity, tumor differentiation, clinical stage and survival were analyzed. Results Our meta-analysis found that higher expression of SPOP was significantly associated with earlier clinical stage, well differentiation and better overall survival. Subgroup analysis showed that the SPOP expression of adjacent tissue was significantly higher than that in cancer tissues of prostate and liver. However, renal cancer presented improved expression of SPOP in cancer tissue. Conclusions SPOP has the potential function to act as a novel and effective biomarker for cancer diagnosis and prognostic stratification.
format article
author Yan He
Jun Chen
Xingchen Peng
Yanli Xia
Yonglin Su
author_facet Yan He
Jun Chen
Xingchen Peng
Yanli Xia
Yonglin Su
author_sort Yan He
title Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
title_short Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
title_full Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
title_fullStr Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
title_full_unstemmed Clinicopathological and prognostic significance of speckle-type POZ protein in cancers: a systematic review and meta-analysis
title_sort clinicopathological and prognostic significance of speckle-type poz protein in cancers: a systematic review and meta-analysis
publisher BMC
publishDate 2021
url https://doaj.org/article/d74b95125b3e4e56ab0cdce7248bd8e1
work_keys_str_mv AT yanhe clinicopathologicalandprognosticsignificanceofspeckletypepozproteinincancersasystematicreviewandmetaanalysis
AT junchen clinicopathologicalandprognosticsignificanceofspeckletypepozproteinincancersasystematicreviewandmetaanalysis
AT xingchenpeng clinicopathologicalandprognosticsignificanceofspeckletypepozproteinincancersasystematicreviewandmetaanalysis
AT yanlixia clinicopathologicalandprognosticsignificanceofspeckletypepozproteinincancersasystematicreviewandmetaanalysis
AT yonglinsu clinicopathologicalandprognosticsignificanceofspeckletypepozproteinincancersasystematicreviewandmetaanalysis
_version_ 1718407924128153600